Sat, May 18, 2013, 2:36 PM EDT - U.S. Markets closed
Amarantus Bioscience - AMBS
The company's MANF technology may hold a cure for Parkinson's disease.
Read the recent Yahoo news.
One of the co-founders of Amgen recently invested in the company and became a member of its board of directors.
Down 70% from its recent high of .20.
The "Brain Mapping Program" will make the company's patented MANF technology invaluable.
Buy a few shares today for under six cents.
6-centz iz a betta deal dan Q wuz when I bot fo 80-centz yeahz ago, aye Bozz?
"Big pharma" partnership in 2013 takes it over $1.00.
Opportunity to get in now for under five cents.
$1.00 within six months is realistic.